Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington’s disease
View ORCID ProfileFilipe B Rodrigues, Lauren M Byrne, Alexander J Lowe, View ORCID ProfileRosanna Tortelli, Mariette Heins, Gunnar Flik, View ORCID ProfileEileanoir B Johnson, View ORCID ProfileEnrico De Vita, View ORCID ProfileRachael I Scahill, View ORCID ProfileFlaviano Giorgini, View ORCID ProfileEdward J Wild
doi: https://doi.org/10.1101/2020.08.06.20169524
Filipe B Rodrigues
1UCL Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK
Lauren M Byrne
1UCL Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK
Alexander J Lowe
1UCL Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK
Rosanna Tortelli
1UCL Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK
Mariette Heins
2Charles River Laboratories, Groningen, the Netherlands
Gunnar Flik
2Charles River Laboratories, Groningen, the Netherlands
Eileanoir B Johnson
1UCL Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK
Enrico De Vita
3Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, UK
4Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King’s College London, UK
Rachael I Scahill
1UCL Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK
Flaviano Giorgini
5Department of Genetics and Genome Biology, University of Leicester, Leicester, UK
Edward J Wild
1UCL Huntington’s Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The data that support the findings of this study are available on request from the corresponding author, EJW. The data are not publicly available due to their containing information that could compromise the privacy of research participants.
Posted August 07, 2020.
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington’s disease
Filipe B Rodrigues, Lauren M Byrne, Alexander J Lowe, Rosanna Tortelli, Mariette Heins, Gunnar Flik, Eileanoir B Johnson, Enrico De Vita, Rachael I Scahill, Flaviano Giorgini, Edward J Wild
medRxiv 2020.08.06.20169524; doi: https://doi.org/10.1101/2020.08.06.20169524
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington’s disease
Filipe B Rodrigues, Lauren M Byrne, Alexander J Lowe, Rosanna Tortelli, Mariette Heins, Gunnar Flik, Eileanoir B Johnson, Enrico De Vita, Rachael I Scahill, Flaviano Giorgini, Edward J Wild
medRxiv 2020.08.06.20169524; doi: https://doi.org/10.1101/2020.08.06.20169524
Subject Area
Subject Areas
- Addiction Medicine (339)
- Allergy and Immunology (665)
- Anesthesia (179)
- Cardiovascular Medicine (2621)
- Dermatology (220)
- Emergency Medicine (396)
- Epidemiology (12161)
- Forensic Medicine (10)
- Gastroenterology (754)
- Genetic and Genomic Medicine (4053)
- Geriatric Medicine (383)
- Health Economics (674)
- Health Informatics (2616)
- Health Policy (996)
- Hematology (359)
- HIV/AIDS (839)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3823)
- Nursing (208)
- Nutrition (569)
- Oncology (2004)
- Ophthalmology (580)
- Orthopedics (238)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1106)
- Primary Care Research (445)
- Public and Global Health (6493)
- Radiology and Imaging (1384)
- Respiratory Medicine (868)
- Rheumatology (399)
- Sports Medicine (338)
- Surgery (440)
- Toxicology (52)
- Transplantation (185)
- Urology (165)